Single Triple Therapy Inhaler
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Single Triple Therapy Inhaler, covering 2025-09-25 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation [Phase 4]